KOPRAN
Back to All Ratios
|
KOPRAN Last 5 Year EV/CE History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| EV/CE(x) | 1.45 | 2.25 | 1.16 | 2.25 | 1.17 |
What is the latest EV/CE ratio of KOPRAN ?
| Year | EV/CE |
|---|---|
| Mar2025 | 1.45 |
| Mar2024 | 2.25 |
| Mar2023 | 1.16 |
| Mar2022 | 2.25 |
| Mar2021 | 1.17 |
How is EV/CE of KOPRAN Trending?
| Years | EV/CE | % Change | |
|---|---|---|---|
| Mar2025 | 1.45 | -35.56 | |
| Mar2024 | 2.25 | 93.97 | |
| Mar2023 | 1.16 | -48.44 | |
| Mar2022 | 2.25 | 92.31 | |
| Mar2021 | 1.17 | - | |
Other Financial Ratios of KOPRAN
| Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare EV/CE ratio of peers of KOPRAN
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KOPRAN | ₹687.8 Cr | -9.2% | -16% | -52.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹421,419.0 Cr | 2.5% | 4% | -3.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹172,857.0 Cr | -1% | 0.5% | 9.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹129,953.0 Cr | 6.9% | 8.7% | 21% | Stock Analytics | |
| CIPLA | ₹123,722.0 Cr | 1.4% | -2.4% | -3.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,906.0 Cr | 2.4% | -2.2% | -4.5% | Stock Analytics | |
KOPRAN Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KOPRAN | -9.2% |
-16% |
-52.8% |
| SENSEX | 1.6% |
2.7% |
6.3% |
You may also like the below Video Courses